Tarsus Pharmaceuticals Inc (TARS) — Cash Flow Reinvestment Rate
Tarsus Pharmaceuticals Inc (TARS) has a Cash Flow Reinvestment Rate of 3.21x as of December 2025, reinvesting $61.99 Million (capex $6.36 Million plus investments $55.63 Million) from operating cash flow of $19.33 Million. Check TARS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tarsus Pharmaceuticals Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Tarsus Pharmaceuticals Inc across 1 annual periods. Explore how much of Tarsus Pharmaceuticals Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tarsus Pharmaceuticals Inc (2021–2021)
Year-by-year capital reinvestment analysis for Tarsus Pharmaceuticals Inc. For live market cap and broader valuation context, see Tarsus Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.31x | $1.17 Million | $3.75 Million | $586.00K | — |